RHYTHM PHARMACEUTICALS, INC.
RYTM
43 insider filings · Latest: Sep 14, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | Feb 20 2:02 AM | Hunter C SmithChief Financial Officer | Sale | 4,385 | $101.26 | $444.0K | 110,512(D) | View → |
| Feb 17, 2026 | Feb 20 2:02 AM | Hunter C SmithChief Financial Officer | Sale | 3,569 | $101.38 | $361.8K | 114,897(D) | View → |
| Feb 12, 2026 | Feb 13 1:56 AM | Hunter C SmithChief Financial Officer | Sale | 1,592 | $98.23 | $156.4K | 118,466(D) | View → |
| Feb 11, 2026 | Feb 13 1:56 AM | Hunter C SmithChief Financial Officer | Sale | 2,766 | $98.61 | $272.8K | 120,058(D) | View → |
| Feb 10, 2026 | Feb 13 1:56 AM | Hunter C SmithChief Financial Officer | Sale | 2,713 | $103.00 | $279.4K | 122,824(D) | View → |
| Feb 5, 2026 | Feb 6 11:38 PM | Hunter C SmithChief Financial Officer | Sale | 3,381 | $106.06 | $358.6K | 125,537(D) | View → |
| Feb 4, 2026 | Feb 6 11:38 PM | Hunter C SmithChief Financial Officer | Sale | 3,247 | $105.99 | $344.1K | 128,918(D) | View → |
| Feb 5, 2026 | Feb 5 9:30 PM | HUNTER SMITH | Proposed Sale | 18,406 | $107.97 | $2.0M | — | View → |
| Feb 4, 2026 | Feb 4 9:21 PM | HUNTER SMITH | Proposed Sale | 3,247 | $108.29 | $351.6K | — | View → |
| Dec 11, 2025 | Dec 11 9:25 PM | PAMELA CRAMER | Proposed Sale | 3,350 | $104.77 | $351.0K | — | View → |
| Nov 20, 2025 | Nov 20 9:23 PM | PAMELA CRAMER | Proposed Sale | 3,350 | $103.15 | $345.6K | — | View → |
| Nov 10, 2025 | Nov 10 9:31 PM | PAMELA CRAMER | Proposed Sale | 3,515 | $100.30 | $352.6K | — | View → |
| Nov 7, 2025 | Nov 7 9:38 PM | PAMELA CRAMER | Proposed Sale | 19,351 | $98.49 | $1.9M | — | View → |
| Oct 30, 2025 | Oct 30 8:16 PM | JOSEPH SHULMAN | Proposed Sale | 9,748 | $113.89 | $1.1M | — | View → |
| Oct 28, 2025 | Oct 28 8:17 PM | JOSEPH SHULMAN | Proposed Sale | 2,815 | $111.55 | $314.0K | — | View → |
| Oct 16, 2025 | Oct 16 8:20 PM | JOSEPH SHULMAN | Proposed Sale | 14,437 | $109.35 | $1.6M | — | View → |
| Sep 2, 2025 | Sep 2 8:41 PM | JOSEPH SHULMAN | Proposed Sale | 16,781 | $103.15 | $1.7M | — | View → |
| Aug 21, 2025 | Aug 21 8:45 PM | JOSEPH SHULMAN | Proposed Sale | 4,188 | $98.70 | $413.4K | — | View → |
| Aug 12, 2025 | Aug 12 8:28 PM | HUNTER SMITH | Proposed Sale | 28,088 | $94.31 | $2.6M | — | View → |
| Aug 12, 2025 | Aug 12 8:26 PM | CHRISTOPHER PAUL GERMAN | Proposed Sale | 1,500 | $94.31 | $141.5K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Sep 14 11:37 PM | David P MeekerDirector, President and CEO | Option Exercise | 50,000 | $6.05 | 15,431(D) | View → |
| Aug 31, 2026 | Sep 1 8:22 PM | Hunter C SmithChief Financial Officer | Option Exercise | 57,187 | $25.79 | 3,813(D) | View → |
| Aug 17, 2026 | Aug 18 9:35 PM | Manher JoshiChief Medical Officer | Grant/Award | 75,000 | $115.44 | 25,000(D) | View → |
| Aug 13, 2026 | Aug 17 10:00 PM | Joseph ShulmanChief Technical Officer | Option Exercise | 2,024 | $6.80 | 5,945(D) | View → |
| Aug 13, 2026 | Aug 14 11:04 PM | Jennifer Kayden LeeEVP, Head of North America | Option Exercise | 56,601 | $24.29 | 0(D) | View → |
| Aug 12, 2026 | Aug 14 11:01 PM | Yann MazabraudEVP, Head of International | Option Exercise | 46,625 | $6.80 | 35,875(D) | View → |
| Jul 1, 2026 | Jul 2 8:52 PM | Alastair GarfieldChief Scientific Officer | Option Exercise | 4,445 | — | 8,888(D) | View → |
| Jun 24, 2026 | Jun 25 10:09 PM | Christophe JeanDirector | Grant/Award | 6,015 | $107.55 | 2,324(D) | View → |
| Jun 23, 2026 | Jun 25 10:09 PM | Christophe JeanDirector | Option Exercise | 4,712 | — | 0(D) | View → |
| Jun 24, 2026 | Jun 25 10:08 PM | J W Mcgirr DavidDirector | Grant/Award | 6,015 | $107.55 | 2,324(D) | View → |
| Jun 23, 2026 | Jun 25 10:08 PM | J W Mcgirr DavidDirector | Option Exercise | 4,712 | — | 0(D) | View → |
| Jun 24, 2026 | Jun 25 10:06 PM | Lynn A. TetraultDirector | Grant/Award | 6,015 | $107.55 | 2,324(D) | View → |
| Jun 23, 2026 | Jun 25 10:06 PM | Lynn A. TetraultDirector | Option Exercise | 4,712 | — | 0(D) | View → |
| Jun 24, 2026 | Jun 25 10:03 PM | Stuart A ArbuckleDirector | Grant/Award | 6,015 | $107.55 | 2,324(D) | View → |
| Jun 23, 2026 | Jun 25 10:03 PM | Stuart A ArbuckleDirector | Option Exercise | 4,712 | — | 0(D) | View → |
| Jun 24, 2026 | Jun 25 10:01 PM | Jennifer L GoodDirector | Grant/Award | 6,015 | $107.55 | 2,324(D) | View → |
| Jun 23, 2026 | Jun 25 10:01 PM | Jennifer L GoodDirector | Option Exercise | 4,712 | — | 0(D) | View → |
| Jun 22, 2026 | Jun 24 8:15 PM | Lynn A. TetraultDirector | Option Exercise | 37,000 | $28.27 | 0(D) | View → |
| May 18, 2026 | May 20 8:15 PM | Hunter C SmithChief Financial Officer | Option Exercise | 3,000 | $17.87 | 79,000(D) | View → |
| May 15, 2026 | May 19 8:15 PM | Christopher Paul GermanCorporate Controller & CAO | Option Exercise | 4,442 | $56.69 | 2,325(D) | View → |
Page 1 of 3
Next →